These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330 [TBL] [Abstract][Full Text] [Related]
3. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer. Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906 [TBL] [Abstract][Full Text] [Related]
5. Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431 [TBL] [Abstract][Full Text] [Related]
6. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Iagaru A; Mittra E; Dick DW; Gambhir SS Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL; Xue YL; Song HJ; Luo QY Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353 [TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655 [TBL] [Abstract][Full Text] [Related]
10. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design. Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597 [TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Chakraborty D; Bhattacharya A; Mete UK; Mittal BR Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT. Dyrberg E; Larsen EL; Hendel HW; Thomsen HS Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360 [TBL] [Abstract][Full Text] [Related]
14. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases. Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of Na[ Usmani S; Ahmed N; Gnanasegaran G; Al Kandari F; Marafi F; Bani-Mustafa A; Musbah A; Jassem Almashmoum M; Van den Wyngaert T Acta Oncol; 2022 Oct; 61(10):1230-1239. PubMed ID: 35862646 [TBL] [Abstract][Full Text] [Related]
16. 18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer. Rao L; Zong Z; Chen Z; Wang X; Shi X; Yi C; Zhang X Medicine (Baltimore); 2016 Apr; 95(16):e3490. PubMed ID: 27100456 [TBL] [Abstract][Full Text] [Related]
18. Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS Ann Nucl Med; 2019 May; 33(5):351-361. PubMed ID: 30877561 [TBL] [Abstract][Full Text] [Related]
19. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356 [TBL] [Abstract][Full Text] [Related]
20. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]